PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway
Physiological Reports · 2025
DOI: 10.14814/phy2.70162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Yifan Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Pathophysiology, Medical College of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Cisplatin, Phosphotransferases (Alcohol Group Acceptor), Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Cisplatin is a widely used anticancer drug, but its accumulation in renal tubular epithelial cells (TECs) can cause acute kidney injury. Phosphoseryl‐tRNA kinase (PSTK) is an intermediate product produced under oxidative stress conditions. This study aimed to elucidate whether PSTK could protect TECs and its possible mechanisms. We found that PSTK levels decreased after cisplatin treatment, but PSTK overexpression using lentivirus vectors protected TEC viability. Overexpression of PSTK increased selenoprotein concentrations and reduced intracellular ROS levels. Additionally, PSTK overexpression inhibited the BAX/BCL2/Caspase 3 pathway after cisplatin stimulation, suggesting its potential role in preventing cell apoptosis. Taken together, this study suggests that PSTK could protect TEC viability from cisplatin‐induced injury, possibly by inhibiting mitochondrial apoptosis. The study is significant for developing therapeutic strategies that could manipulate PSTK to delay AKI progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Pathophysiology, Medical College of Soochow University, Suzhou, Jiangsu, China.
- Department of Thoracic Surgery, School of Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
- School of Biology & Basic Medical Sciences, Medical College of Soochow University, Suzhou, Jiangsu, China.
- Department of Oncology, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
- Liangxi Taihu Hospital of Traditional Chinese Medicine, Wuxi, Jiangsu, China.
- National Heart and Lung Institute Imperial College London, London, UK.
ORCID-Profile: Ziqi Zhou, Dong Zheng
Förderung
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Wu, Y., Xv, Y., Zhao, L., Zhou, Z., Wang, M., Xi, J., Liming, Y., Gao, J., Deng, B., & Zheng, D. (2025). PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway. Physiological Reports. https://doi.org/10.14814/phy2.70162
Vancouver
Wu Y, Xv Y, Zhao L, Zhou Z, Wang M, Xi J, et al. PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway. Physiological Reports. 2025. doi:10.14814/phy2.70162
BibTeX
@article{Wu2025,
author = {Wu, Yifan and Xv, Yuanyuan and Zhao, Limei and Zhou, Ziqi and Wang, Miaomiao and Xi, Jima and Liming, Ying and Gao, Jianling and Deng, Bingqing and Zheng, Dong},
title = {PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70162}
}
EUVIMED